| Systematic (IUPAC) name | |
|---|---|
| 2-(3-[5-(2-hydroxypropan-2-yl)benzimidazol-1-yl]phenyl)benzonitrile | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 951650-22-9 |
| ATC code | ? |
| PubChem | CID 16747643 |
| Chemical data | |
| Formula | C23H19N3O |
| Mol. mass | 353.416 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
NS-11394 is a drug which acts as a subtype-selective positive allosteric modulator at GABAA receptors, with selectivity for the α3 and α5 subtypes.[1][2] It has been researched as an analgesic for use in chronic or neuropathic pain.[3]
|
|||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)